KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Rigel Pharmaceuticals (RIGL) over the last 17 years, with Q3 2025 value amounting to $27.6 million.

  • Rigel Pharmaceuticals' Non-Current Assets fell 1622.06% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.2 million, marking a year-over-year decrease of 117.76%. This contributed to the annual value of $28.9 million for FY2024, which is 6077.18% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Non-Current Assets of $27.6 million as of Q3 2025, which was down 1622.06% from $31.3 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Non-Current Assets registered a high of $34.0 million during Q1 2024, and its lowest value of $5.2 million during Q3 2022.
  • For the 5-year period, Rigel Pharmaceuticals' Non-Current Assets averaged around $20.8 million, with its median value being $18.4 million (2022).
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Non-Current Assets crashed by 6646.56% in 2022, and later surged by 29272.59% in 2023.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Non-Current Assets stood at $12.9 million in 2021, then surged by 42.88% to $18.4 million in 2022, then dropped by 2.27% to $18.0 million in 2023, then soared by 60.77% to $28.9 million in 2024, then decreased by 4.38% to $27.6 million in 2025.
  • Its Non-Current Assets was $27.6 million in Q3 2025, compared to $31.3 million in Q2 2025 and $29.4 million in Q1 2025.